Street Calls of the Week

This week's analyst calls featured Wells Fargo initiating Duolingo (DUOL) at Underweight, citing persistent user apathy, stalled growth, and a frothy valuation. Conversely, JPMorgan upgraded Sealed Air (SEE) to Overweight, highlighting its strong free cash flow generation and attractive valuation, while UBS upgraded Gossamer Bio (GOSS) to Buy, betting on a successful Phase 3 trial for its PAH drug. DA Davidson upgraded Nvidia (NVDA) to Buy, emphasizing its undisputed leadership in the relentless AI compute demand surge, but BofA downgraded Array Technologies (ARRY) to Underperform due to mounting tariff risks and margin erosion.

Analysis

This week's analyst actions highlight diverging fundamentals across technology, industrial, and biotech sectors. Duolingo (DUOL) received an Underweight initiation from Wells Fargo, citing persistent user apathy and stalling growth, with daily active user growth decelerating to 40% in Q2 from 48% in Q1. The firm noted that monetization efforts are backfiring, evidenced by a drop in five-star app reviews from 60% to 30%, and considers the stock's valuation of 23x 2027 EBITDA to be excessive given these headwinds. In contrast, JPMorgan upgraded Sealed Air (SEE) to Overweight, framing it as a value opportunity with a robust 8% free cash flow yield projected for 2025 and 2026. The firm sees a positive inflection in its Protective segment and argues the stock trades at a discount, noting its superior margins compared to peers acquired at higher multiples. In biotech, Gossamer Bio (GOSS) was upgraded to Buy by UBS based on the high-risk, high-reward potential of its seralutinib drug for PAH, with a pivotal Phase 3 trial readout in February potentially driving 100-200% upside or a 90% decline. For mega-cap tech, DA Davidson upgraded Nvidia (NVDA) to Buy, asserting that relentless AI compute demand will sustain its ~40% earnings growth, making its 28x CY26 earnings multiple more attractive than Apple's identical multiple for just 9% growth. Finally, BofA downgraded Array Technologies (ARRY) to Underperform, warning that mounting tariff risks in India and Mexico and margin pressures make its 28-29% FY25 gross margin target unattainable, rendering its valuation premium to peers unjustified.

Key Decisions for Investors

• Investors in Duolingo should monitor user growth and app engagement metrics closely, as the current negative sentiment and high valuation suggest significant downside risk if brand apathy persists and monetization strategies fail to gain traction.
• Value-focused investors might consider Sealed Air, as its projected 8% free cash flow yield and valuation discount to private market value present a compelling case for potential upside, contingent on the expected recovery in its Protective segment.
• Gossamer Bio represents a binary, event-driven trade for investors with a high-risk tolerance; exposure should be carefully sized ahead of the February Phase 3 trial data, which is expected to cause extreme share price volatility.
• Given the downgrade of Array Technologies due to tariff and margin risks, investors should re-evaluate solar sector exposure and consider favoring secular growth themes like AI, where Nvidia is seen by some analysts as having a more durable growth runway despite its high valuation.